A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.
A protective vaccine against HIV-1 will likely require the elicitation of a broadly neutralizing antibody (bNAb) response. Although the development of an immunogen that elicits such antibodies remains elusive, a proportion of HIV-1 infected individuals evolve broadly neutralizing serum responses ove...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-08-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC2916884?pdf=render |